vimarsana.com
Home
Live Updates
Enzymatica Interim report Q1/2024: MDR certification opens up great commercial opportunities : vimarsana.com
Enzymatica Interim report Q1/2024: MDR certification opens up great commercial opportunities
/PRNewswire/ -- First quarter Net sales reached SEK 9.4 (13.0) million. The operating result totaled SEK -18.4 (-14.4) million. Earnings per share, basic and...
Related Keywords
United Kingdom ,
Sweden ,
Geneva ,
Genè ,
Switzerland ,
British ,
Swedish ,
Stefan Olsson ,
Claus Egstrand ,
Assessment Of Social Services ,
University Of Kent ,
Enzymatica Certified Adviser Is Carnegie Investment Bank ,
Global Health Summit In Geneva ,
Swedish Agency For Health Technology Assessment ,
Global Health Campaign ,
Device Directive ,
Professor Glen ,
World Conference ,
British Journal ,
Sports Medicine ,
Global Health Summit ,
Swedish Agency ,
Health Technology Assessment ,
Social Services ,
Chief Executive Officer ,
Communication Manager ,
Nasdaq First North Growth ,
Certified Adviser ,
Carnegie Investment Bank ,
vimarsana.com © 2020. All Rights Reserved.